Article
CommunityJev Models & Reimplementations
TrialJev
Open-weight eligibility scorer that LoRA-adapts Qwen models with a pointer head to score natural-language answer options in one forward pass, trained on TREC Clinical Trials 2021 and evaluated on 6,975 pairs from 50 unseen synthetic patients.
- Format
- Article
- Reading time
- 2 min
- Published by
- Community
- Added
- Nov 2026
Highlights
- Scores natural-language answer options in a single forward pass with no autoregressive decoding.
- Reaches 80.97% (Qwen3.5-27B) and 81.84% (Qwen3.8-27B) accuracy on 6,975 eligible-or-excluded pairs.
- Verdict generation takes 2.45-2.70 times as long as one-pass inference at 9B-27B in matched batch-1 measurements.
- Runs locally on a single GPU at roughly 178 ms per pair at 27B, without sending patient text to an external API.
- Adapters, pointer heads, and model cards are released on Hugging Face.
Questions about this entry
Short answers drawn from the linked project or page.
The paper reports that adapters, pointer heads, and model cards are released on Hugging Face. TrialJev runs locally on a single GPU and requires approximately 178 ms per pair at 27B, without transmitting patient text to an external model API.
On 6,975 eligible-or-excluded pairs from 50 unseen TREC 2022 synthetic patients, TrialJev achieves 80.97% accuracy with Qwen3.5-27B and 81.84% with Qwen3.8-27B.
Under a common development-fitted decision correction, the two 27B TrialJev models reach 80.99% and 81.88% accuracy, compared with 81.28% for the proprietary hosted Jev API. The paired confidence intervals include zero.
TrialJev is trained on TREC Clinical Trials 2021 and evaluated on 6,975 eligible-or-excluded pairs drawn from 50 unseen TREC 2022 synthetic patients.
No. TrialJev runs locally on a single GPU, so patient text is not transmitted to an external model API. The paper frames this as useful under restrictions on sharing patient records.
An A/B-logit ablation shows that avoiding decoding, rather than the pointer head alone, accounts for the measured efficiency advantage over LLMs fine-tuned to generate verdicts.
Evaluation is limited to synthetic patients and implementation-specific timing, and clinical use has not been validated. TrialJev is intended for first-pass prioritization of candidate trials, complementing rather than replacing explanatory models and clinical review.
Reactions & coverage
Posts, threads, and videos about this entry from around the web.
X: Standard One SH (StandardThinking)
LinkedIn: What multimodal decision models actually change, and what they do not.
LinkedInJevDirectory.org
Hacker News: Decision Index 0.2.1 scores open reproductions of Jev on a frozen suite.
jackbravo4 pointsDecision Index 0.2.1 – 70 open reproductions of TypeSafe Jev's Decision ModelRead the thread on Hacker NewsHacker News: Pointer to a DiffusionGemma plus vLLM tutorial for a Jev-shaped classifier.
1 pointHow to build a Jev-style classifier with DiffusionGemma and vLLMRead the thread on Hacker NewsFrom the Jev guides
Original write-ups on what this entry is for.
From the Jev AI model community
Posts from builders shipping with Jev right now.